|
QuintilesIMS Real-World Insights Bibliography
| Using Certification to Promote Uptake of Real-World Evidence by Payers |
| Author(s): Jodi B. Segal, Joel D. Kallich, Emma R. Oppenheim, Louis P. Garrison Jr., Sheikh Usman Iqbal, Marla Kessler, G. Caleb Alexander |
| Affiliations(s): 1Co-director, Center for Drug Safety and Effectiveness, Johns Hopkins University, and Professor of Medicine and Epidemiology, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine/Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
2Principal, Big Health Data, Falmouth, Maine.
3Master’s Student, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
4Professor of Pharmaceutical Outcomes Research and Policy, School of Pharmacy, University of Washington, Seattle.
5Senior Medical Affairs Leader−Neuroscience, Global Medical Affairs, AstraZeneca, Cambridge, Massachusetts.
6Vice President, Global Services and Real-World Evidence Solutions, IMS Health, Plymouth Meeting, Pennsylvania.
7Co-director, Center for Drug Safety and Effectiveness, Johns Hopkins University, and Associate Professor of Medicine and Epidemiology, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine/Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. |
| Publication(s): J Manag Care Spec Pharm, 2016 Mar;22(3):191-196. |
| Document Type(s): Article |
| Countries: USA |
| Click here for the abstract |
C:
Y: |
Database Validity and methodology, Health policy
2016 |
|
L:
A: |
English
Review |
|
 |
| |
| |
| Italian electronic health records mapping: is clinical data collection getting in line with the real world evidence era? |
| Author(s): Avitabile A, Caputo A, Gilardelli G, Golotta C, La Grasta L, Heiman F1, Porrello N. |
| Affiliations(s): 1 IMS Health Information Solutions Italy Srl, Milan, Italy. |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Poster |
| Countries: Italy |
C:
Y: |
Health policy, Neurological disorders, Oncology
2016 |
|
L:
A: |
English
Clinical setting: hospital, Real World Data, Real World Evidence |
|
|
| |
| |
| Comparison of biosimilar guideline and real consumption among Italian regions. |
| Author(s): Tettamanti A1, Tucci C1, Urbinati D1. |
| Affiliations(s): 1 IMS Health, Milan, Italy. |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Poster |
| Countries: Italy |
C:
Y: |
Guidelines, Health policy
2016 |
|
L:
A: |
English
Review |
|
|
| |
| |
| Regional market access pathways for diagnostics in Italy. |
| Author(s): Mantuano M1, Dionisi M2, Paolini D2, Gancitano G2, Urbinati D1 |
| Affiliations(s): 1 IMS Health, Milan, Italy 2 Roche Diagnostics, Italy. |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Poster |
| Countries: Italy |
C:
Y: |
Health policy, Pricing and reimbursement, Regulatory
2016 |
|
L:
A: |
English
Review |
|
|
| |
| |
| The impact of regional legislative measures on the prescription of off-patent medicines. |
| Author(s): Tettamanti A1, Tucci C1, Urbinati D1. |
| Affiliations(s): IMS Health, Milan, Italy |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Poster |
| Countries: Italy |
C:
Y: |
Guidelines, Health policy
2016 |
|
L:
A: |
English
Review |
|
|
| |
| |
| Regional time to market of innovative drugs in Italy. |
| Author(s): Mantuano M1, Daniel F1, Urbinati D1. |
| Affiliations(s): IMS Health, Milan, Italy. |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Poster |
| Countries: Italy |
C:
Y: |
Health policy
2016 |
|
L:
A: |
English
Review |
|
|
| |
| |
| Development and validation of an electronic frailty index using routine primary care electronic health record data |
| Author(s): Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, Mohammed MA, Parry J, Marshall T |
| Affiliations(s): Academic Unit of Elderly Care and Rehabilitation, University of Leeds; ResearchOne, TPP, Leeds, West Yorkshire; Academic Unit of Elderly Care and Rehabilitation, University of Leeds; Institute of Applied Health Research, University of Birmingham; Faculty of Health Studies, University of Bradford; SystmOne, TPP, Leeds, West Yorkshire |
| Publication(s): |
| Document Type(s): Article |
| Countries: UK |
C:
Y: |
Health policy
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| An audit of patients transferred out of The Health Improvement Network (THIN) – A UK primary care database |
| Author(s): Myland M, Ansell D,Bourke A,Hill F,O’Leary C,Waples C,Nasser A |
| Affiliations(s): IMS Health
|
| Publication(s): 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)
Boston, USA
|
| Document Type(s): Poster, Presentation |
| Countries: USA |
C:
Y: |
Health policy
2015 |
|
L:
A: |
English
Database Study, Retrospective database analysis |
|
|
| |
| |
| DOES CONDITIONAL MARKETING AUTHORISATION INFLUENCE MARKET ACCESS IN FRANCE, ENGLAND, AND GERMANY? |
| Author(s): Kaaniche A1, Troubat A1, Sherwood A2 |
| Affiliations(s): 1IMS, PARIS, France, 2IMS Health, La Défense, France |
| Publication(s): ISPOR 18th Annual European Congress
Milan, Italy
November, 2015 |
| Document Type(s): Abstract, Poster |
| Countries: France, Germany, UK |
C:
Y: |
Health policy, Pricing and reimbursement
2015 |
|
L:
A: |
English
Market impact |
|
|
| |
| |
| LISTE-EN-SUS REFORM IN FRANCE - WHAT ARE THE CONSEQUENCES? |
| Author(s): Mitrano M, Flostrand S |
| Affiliations(s): IMS Consulting Group, Paris, France |
| Publication(s): ISPOR 18th Annual European Congress
Milan, Italy
November, 2015 |
| Document Type(s): Poster |
| Countries: France |
C:
Y: |
Health policy
2015 |
|
L:
A: |
English
Market impact |
|
|
| |
| |
 1 of 9 
|
|
